We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

Technology Holdings, Inc. (NASDAQ:CELZ), a clinical-stage biotechnology firm, has announced a strategic collaboration with Greenstone Biosciences Inc. to utilize Artificial Intelligence (AI) in ...

First Mouse With Two Male Parents to Reach Adulthood Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a ...

One of the most exciting developments in diabetes treatment is the use of new medications that help control blood sugar in ...

The company registered an operating income of $635M in 2018, growing to $3.3B in 2022. Vertex is by far the largest company in this list, but not so large that its stem cell therapy for diabetes would ...

Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs) — are the common predecessors of cells of the mesenchymal lineage, such as bone, cartilage and fat ...

ANTEROGEN, a developer of stem cell therapies, has seen its stock drop more than 20% on the 3rd after failing to prove the ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte ... hold on a phase 1/2 trial of VX-880 – a stem cell therapy Vertex acquired through its near $1 ...

Josh Wolfe, co-founder of Lux Capital, discussed the current AI space and the increasing importance of both capital and human ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

We interview the winners of the L’Oréal-UNESCO For Women in Science Awards 2024, exploring their inspiring journeys ...